Letter
Effectiveness of omalizumab in severe solar urticaria

https://doi.org/10.1016/j.anai.2015.12.023Get rights and content

First page preview

First page preview
Click to open first page preview

References (11)

There are more references available in the full text version of this article.

Cited by (14)

  • Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence

    2018, Journal of Allergy and Clinical Immunology
    Citation Excerpt :

    The advanced search option was used with the terms “omalizumab” AND, for example, “cold urticaria” to encompass results from all fields. This was complemented by any additional published or in press evidence known to us at the time of publication (Table II).19,20,36-76 All publications have been included, regardless of whether the results were positive or negative, to present a fair and unbiased account of the available published evidence.

View all citing articles on Scopus

Disclosures: Dr Dávila states that he has received fees as a panelist and advisory member from Novartis and Faes Farma. The other authors declare that they have no relevant conflicts of interest.

View full text